Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Telomerase reverse transcriptase regulates microRNAs.

Lassmann T, Maida Y, Tomaru Y, Yasukawa M, Ando Y, Kojima M, Kasim V, Simon C, Daub CO, Carninci P, Hayashizaki Y, Masutomi K.

Int J Mol Sci. 2015 Jan 6;16(1):1192-208. doi: 10.3390/ijms16011192.

2.

Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells.

Yamaguchi S, Maida Y, Yasukawa M, Kato T, Yoshida M, Masutomi K.

PLoS One. 2014 Nov 6;9(11):e112438. doi: 10.1371/journal.pone.0112438. eCollection 2014.

3.

Concurrent estrogen action was essential for maximal progestin effect in oral contraceptives.

Bono Y, Kyo S, Kiyono T, Mizumoto Y, Nakamura M, Maida Y, Takakura M, Fujiwara H.

Fertil Steril. 2014 May;101(5):1337-43. doi: 10.1016/j.fertnstert.2014.02.005. Epub 2014 Mar 19.

PMID:
24656887
4.

Involvement of telomerase reverse transcriptase in heterochromatin maintenance.

Maida Y, Yasukawa M, Okamoto N, Ohka S, Kinoshita K, Totoki Y, Ito TK, Minamino T, Nakamura H, Yamaguchi S, Shibata T, Masutomi K.

Mol Cell Biol. 2014 May;34(9):1576-93. doi: 10.1128/MCB.00093-14. Epub 2014 Feb 18.

5.

Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.

Nakamura M, Zhang X, Mizumoto Y, Maida Y, Bono Y, Takakura M, Kyo S.

Int J Oncol. 2014 Mar;44(3):669-77. doi: 10.3892/ijo.2013.2230. Epub 2013 Dec 23.

PMID:
24366104
6.

Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells.

Zhang X, Kyo S, Nakamura M, Mizumoto Y, Maida Y, Bono Y, Takakura M, Fujiwara H.

Cancer Lett. 2014 Apr 1;345(1):106-14. doi: 10.1016/j.canlet.2013.11.020. Epub 2013 Dec 11.

PMID:
24333732
7.

Off-Target Effect of Endogenous siRNA Derived from RMRP in Human Cells.

Maida Y, Kyo S, Lassmann T, Hayashizaki Y, Masutomi K.

Int J Mol Sci. 2013 Apr 29;14(5):9305-18. doi: 10.3390/ijms14059305.

8.

The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.

Nakamura M, Takakura M, Fujii R, Maida Y, Bono Y, Mizumoto Y, Zhang X, Kiyono T, Kyo S.

Cancer Lett. 2013 Aug 9;336(1):68-75. doi: 10.1016/j.canlet.2013.04.010. Epub 2013 Apr 18.

PMID:
23603247
9.

Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers.

Takakura M, Kyo S, Nakamura M, Maida Y, Mizumoto Y, Bono Y, Zhang X, Hashimoto Y, Urata Y, Fujiwara T, Inoue M.

Br J Cancer. 2012 Jul 24;107(3):448-54. doi: 10.1038/bjc.2012.276. Epub 2012 Jun 26.

10.

Creation of immortalised epithelial cells from ovarian endometrioma.

Bono Y, Kyo S, Takakura M, Maida Y, Mizumoto Y, Nakamura M, Nomura K, Kiyono T, Inoue M.

Br J Cancer. 2012 Mar 13;106(6):1205-13. doi: 10.1038/bjc.2012.26. Epub 2012 Feb 21.

11.

Maintenance of tumor initiating cells of defined genetic composition by nucleostemin.

Okamoto N, Yasukawa M, Nguyen C, Kasim V, Maida Y, Possemato R, Shibata T, Ligon KL, Fukami K, Hahn WC, Masutomi K.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20388-93. doi: 10.1073/pnas.1015171108. Epub 2011 Jul 5.

12.

Stem cells in endometrium and endometrial cancer: accumulating evidence and unresolved questions.

Kyo S, Maida Y, Inoue M.

Cancer Lett. 2011 Sep 28;308(2):123-33. doi: 10.1016/j.canlet.2011.05.015. Epub 2011 Jun 17. Review.

PMID:
21683518
13.

Comparison of telomere length and association with progenitor cell markers in lacrimal gland between Sjögren syndrome and non-Sjögren syndrome dry eye patients.

Kawashima M, Kawakita T, Maida Y, Kamoi M, Ogawa Y, Shimmura S, Masutomi K, Tsubota K.

Mol Vis. 2011;17:1397-404. Epub 2011 May 27.

14.

Activation of NF-kappaB is a novel target of KRAS-induced endometrial carcinogenesis.

Mizumoto Y, Kyo S, Kiyono T, Takakura M, Nakamura M, Maida Y, Mori N, Bono Y, Sakurai H, Inoue M.

Clin Cancer Res. 2011 Mar 15;17(6):1341-50. doi: 10.1158/1078-0432.CCR-10-2291.

15.

Two-step cleavage of hairpin RNA with 5' overhangs by human DICER.

Ando Y, Maida Y, Morinaga A, Burroughs AM, Kimura R, Chiba J, Suzuki H, Masutomi K, Hayashizaki Y.

BMC Mol Biol. 2011 Feb 9;12:6. doi: 10.1186/1471-2199-12-6.

16.

RNA-dependent RNA polymerases in RNA silencing.

Maida Y, Masutomi K.

Biol Chem. 2011 Apr;392(4):299-304. doi: 10.1515/BC.2011.035. Epub 2011 Feb 7. Review.

PMID:
21294682
17.

Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.

Kyo S, Sakaguchi J, Kiyono T, Shimizu Y, Maida Y, Mizumoto Y, Mori N, Nakamura M, Takakura M, Miyake K, Sakamoto M, Inoue M.

Clin Cancer Res. 2011 Feb 1;17(3):525-37. doi: 10.1158/1078-0432.CCR-10-1287. Epub 2010 Dec 3.

18.

Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer.

Nakamura M, Kyo S, Zhang B, Zhang X, Mizumoto Y, Takakura M, Maida Y, Mori N, Hashimoto M, Ohno S, Inoue M.

Hum Pathol. 2010 Nov;41(11):1516-29. doi: 10.1016/j.humpath.2010.05.006. Epub 2010 Aug 30.

PMID:
20800872
19.

Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer.

Mori N, Kyo S, Nakamura M, Hashimoto M, Maida Y, Mizumoto Y, Takakura M, Ohno S, Kiyono T, Inoue M.

Br J Cancer. 2010 Sep 7;103(6):889-98. doi: 10.1038/sj.bjc.6605805. Epub 2010 Jul 27.

20.

Bone marrow-derived cells from male donors can compose endometrial glands in female transplant recipients.

Ikoma T, Kyo S, Maida Y, Ozaki S, Takakura M, Nakao S, Inoue M.

Am J Obstet Gynecol. 2009 Dec;201(6):608.e1-8. doi: 10.1016/j.ajog.2009.07.026. Epub 2009 Oct 3.

PMID:
19800602
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk